Found: 14
Select item for more details and to access through your institution.
Once-weekly exenatide formulation better than twice-daily regimen.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
Improvement of glycemic control, triglycerides, and HDL cholesterol levels with muraglitazar, a dual (alpha/gamma) peroxisome proliferator-activated receptor activator, in patients with type 2 diabetes inadequately controlled with metformin monotherapy: A double-blind, randomized, pioglitazone-comparative study.
- Published in:
- 2006
- By:
- Publication type:
- Journal Article
Thiazolidinediones: the case for early use.
- Published in:
- 2006
- By:
- Publication type:
- journal article
A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia: response to Goldberg et al.
- Published in:
- 2005
- By:
- Publication type:
- research
A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia: response to Goldberg et al.
- Published in:
- 2005
- By:
- Publication type:
- Letter
A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Assessment of group versus individual diabetes education: a randomized study.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Review: insulin monotherapy and insulin combined with oral hypoglycemic agents provide similar glycemic control.
- Published in:
- 2005
- By:
- Publication type:
- Journal Article
Review: short-acting insulin analogues reduce glycosylated hemoglobin more than regular human insulin but only in adults with type 1 diabetes.
- Published in:
- 2005
- By:
- Publication type:
- Journal Article
Blood pressure targets in diabetes: is this the time for change?--PRO (Rebuttal).
- Published in:
- 2011
- By:
- Publication type:
- journal article
Successful islet autotransplantation in humans: functional insulin secretory reserve as an estimate of surviving islet cell mass.
- Published in:
- 1998
- By:
- Publication type:
- journal article
Effect of intensive compared with standard glycemia treatment strategies on mortality by baseline subgroup characteristics: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.
- Published in:
- 2010
- By:
- Publication type:
- journal article
One-year treatment with exenatide improves beta-cell function, compared with insulin glargine, in metformin-treated type 2 diabetic patients: a randomized, controlled trial.
- Published in:
- 2009
- By:
- Publication type:
- journal article
New therapies to achieve glycemic control and weight loss in T2DM.
- Published in:
- 2006
- By:
- Publication type:
- Journal Article